Theranos Gets Additional Week to Respond to U.S. Inspection

  • Blood-test startup has hired new director for California lab
  • Regulators had ordered changes at lab, threatened sanctions

Blood-testing startup Theranos Inc. said it has been given a one-week extension by U.S. regulators to say how it will fix flaws at a California laboratory.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.